The store will not work correctly when cookies are disabled.
1-(2-(5-chloro-2-fluorophenyl)-5-methylpyridin-4-yl)-3-methyl-1H-imidazo[4,5-c]pyridin-2(3H)-one
ID: ALA4515962
PubChem CID: 155540194
Max Phase: Preclinical
Molecular Formula: C19H14ClFN4O
Molecular Weight: 368.80
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(C)c2cnccc21
Standard InChI: InChI=1S/C19H14ClFN4O/c1-11-9-23-15(13-7-12(20)3-4-14(13)21)8-17(11)25-16-5-6-22-10-18(16)24(2)19(25)26/h3-10H,1-2H3
Standard InChI Key: WWSVFSVYBGWGPQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
3.5645 -11.6429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5634 -12.4624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2714 -12.8714 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2696 -11.2340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9782 -11.6393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9785 -12.4624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2672 -10.4168 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8572 -12.8707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1496 -12.4599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4420 -12.8672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4409 -13.6853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1533 -14.0943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8579 -13.6846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5664 -14.0918 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.9237 -9.9373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6688 -9.1608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6015 -9.9412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8553 -9.1629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3087 -8.5560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5082 -8.7261 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2572 -9.5087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8055 -10.1122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7016 -10.1876 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1473 -8.4984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7348 -12.4577 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.6850 -11.2291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
4 7 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
2 8 1 0
13 14 1 0
7 15 1 0
15 16 1 0
16 18 1 0
17 7 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
15 23 2 0
16 24 1 0
10 25 1 0
5 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 368.80 | Molecular Weight (Monoisotopic): 368.0840 | AlogP: 3.89 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.71 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.59 | CX LogP: 3.75 | CX LogD: 3.75 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.54 | Np Likeness Score: -1.43 |
References
1. Wang H, Lawson JD, Scorah N, Kamran R, Hixon MS, Atienza J, Dougan DR, Sabat M.. (2016) Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors., 26 (17): [PMID:27460209] [10.1016/j.bmcl.2016.07.030] |